News and Trends 12 Dec 2016
With a new €120M Infusion, Pocket NGS CEO talks Success and Strategy
…machines for specialized life science labs, this company is democratizing genome sequencing to make it available to nonspecialized users. As Sanghera remarked, “We think long and hard about ubiquitous DNA…